Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Rezpegaldesleukin by Nektar Therapeutics for Alopecia Areata: Likelihood of Approval
Rezpegaldesleukin is under clinical development by Nektar Therapeutics and currently in Phase II for Alopecia Areata. According to GlobalData, Phase...